FSMDX
Price
$31.36
Change
+$0.41 (+1.32%)
Updated
Apr 23 closing price
Net Assets
37.64B
WOOOX
Price
$14.75
Change
+$0.21 (+1.44%)
Updated
Apr 23 closing price
Net Assets
346.98M
Ad is loading...

FSMDX vs WOOOX

Header iconFSMDX vs WOOOX Comparison
Open Charts FSMDX vs WOOOXBanner chart's image
Fidelity Mid Cap Index
Price$31.36
Change+$0.41 (+1.32%)
VolumeN/A
Net Assets37.64B
JPMorgan SMID Cap Equity R3
Price$14.75
Change+$0.21 (+1.44%)
VolumeN/A
Net Assets346.98M
FSMDX vs WOOOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. WOOOX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and WOOOX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 37.6B vs. WOOOX (347M). FSMDX pays higher dividends than WOOOX: FSMDX (1.20) vs WOOOX (0.21). FSMDX was incepted earlier than WOOOX: FSMDX (14 years) vs WOOOX (9 years). WOOOX (1.26) is less costly to investors than FSMDX (0.03). WOOOX is a more actively managed with annual turnover of: 39.00 vs. FSMDX (8.00). FSMDX (0) and WOOOX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 0.81 vs. WOOOX (-3.39). FSMDX return over 5 years is better than : 74.96 vs. WOOOX (6.63).
FSMDXWOOOXFSMDX / WOOOX
Total Expense Ratio0.031.092%
Annual Report Gross Expense Ratio0.031.262%
Fund Existence14 years9 years-
Gain YTD-8.351-11.71871%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets37.6B347M10,836%
Annual Yield % from dividends1.200.21579%
Returns for 1 year0.81-3.39-24%
Returns for 3 years11.80-12.69-93%
Returns for 5 years74.966.631,131%
Returns for 10 years85.27N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRGAX7.03N/A
N/A
DWS RREEF Global Real Estate Secc A
HLMVX32.22N/A
N/A
Harding Loevner Global Equity Inst
PRJCX34.48N/A
N/A
PGIM Jennison Global Opportunities C
PHLQX40.28N/A
N/A
PGIM Jennison Health Sciences R6
NEQAX11.13N/A
N/A
Neuberger Berman U.S. Equity Impact A